Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort.

[1]  Lara A. Kahale,et al.  Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. , 2014, The Cochrane database of systematic reviews.

[2]  A. Turpie,et al.  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. , 2012, The New England journal of medicine.

[3]  A. Ciampi,et al.  Men had a higher risk of recurrent venous thromboembolism than women: a large population study. , 2012, Gender medicine.

[4]  M. Abdelnoor,et al.  Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. , 2011, Thrombosis Research.

[5]  I. Martinelli,et al.  Risk factors for venous and arterial thrombosis. , 2011, Blood transfusion = Trasfusione del sangue.

[6]  S. Kahn,et al.  Determining the test characteristics of claims‐based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database , 2011, Pharmacoepidemiology and drug safety.

[7]  G. Raskob,et al.  Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. , 2010, American Journal of Preventive Medicine.

[8]  S. Barni,et al.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. , 2009, The Lancet. Oncology.

[9]  J. Gore,et al.  Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study , 2009, Journal of Thrombosis and Thrombolysis.

[10]  M. Stauch,et al.  A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Chew,et al.  The incidence of venous thromboembolism among patients with primary lung cancer , 2008, Journal of thrombosis and haemostasis : JTH.

[12]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[13]  O. Yildiz.  Vascular Smooth Muscle and Endothelial Functions in Aging , 2007, Annals of the New York Academy of Sciences.

[14]  M. Beauchesne,et al.  Development and validation of database indexes of asthma severity and control , 2007, Thorax.

[15]  L. Jørgensen,et al.  Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label study , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  R. Goldberg,et al.  The worcester venous thromboembolism study , 2006, Journal of General Internal Medicine.

[17]  P. Whincup,et al.  Effects of older age on fibrin D‐dimer, C‐reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years , 2006, Journal of thrombosis and haemostasis : JTH.

[18]  T. Baglin,et al.  High risk of recurrent venous thromboembolism in men , 2004, Journal of thrombosis and haemostasis : JTH.

[19]  Paul Enright,et al.  Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. , 2004, The American journal of medicine.

[20]  F. Spencer,et al.  Risk Factors for Venous Thromboembolism , 2003, Circulation.

[21]  H. Cohen,et al.  Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. , 2003, The American journal of medicine.

[22]  A. Cohen,et al.  Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. , 2002, The New England journal of medicine.

[23]  R. McLeod,et al.  Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery: Results of the Canadian Colorectal DVT Prophylaxis Trial: A Randomized, Double-Blind Trial , 2001, Annals of surgery.

[24]  J. Olsen,et al.  Prognosis of cancers associated with venous thromboembolism. , 2000, The New England journal of medicine.

[25]  E. Oger.  Incidence of Venous Thromboembolism: A Community-based Study in Western France , 2000, Thrombosis and Haemostasis.

[26]  A R Levy,et al.  Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. , 1999, The Canadian journal of cardiology.

[27]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[28]  L. Melton,et al.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.

[29]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[30]  A. Rimm,et al.  Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991. , 1998, American journal of public health.

[31]  J. Boivin,et al.  Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma. , 1998, Journal of clinical epidemiology.

[32]  L. Welin,et al.  DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE GENERAL POPULATION. THE STUDY OF MEN BORN IN 1913 , 1997 .

[33]  D. Bergqvist.  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessme , 1997 .

[34]  P. Prandoni,et al.  Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. , 1996, American heart journal.

[35]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[36]  A. Levy,et al.  Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. , 1995, American journal of epidemiology.

[37]  J. Birkmeyer,et al.  The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. , 1994, Archives of internal medicine.

[38]  P. Walker,et al.  A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .

[39]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.